By: Anne O. Rice, BS, RDH

Alzheimer’s disease is increasingly treated as a biologically defined, clinically heterogeneous condition — not a single linear pathway from one cause to one outcome. A large contemporary framing emphasizes that dementia risk and Alzheimer’s expression arise from multiple interacting pathways (vascular,
metabolic, inflammatory/immune, neurodegenerative and social/behavioral), and that a sizable fraction of cases could be delayed or reduced by addressing modifiable risks across the life course.1 That “many-paths” reality matters because chronic oral diseases are common, persistent inflammatory exposures that frequently cluster with cardiometabolic risk and aging — exactly the terrain where Alzheimer’s risk accumulates.^1,2

From an oral biology standpoint, periodontitis and caries are not just “local infections.” They are biofilm-driven chronic inflammatory diseases whose systemic fingerprints can be measured (e.g., CRP, IL-6), and whose microbial products can circulate intermittently via bacteremia or vesicle trafficking.³ Human longitudinal evidence links severe periodontitis and tooth loss to a modestly higher dementia risk over long follow-up, while meta-analyses show associations between poor periodontal health (periodontitis, tooth loss, reduced masticatory function) and cognitive impairment — yet these results are heterogeneous and sensitive to adjustment for confounders (smoking, diabetes, socioeconomic status) and to reverse causality (cognitive decline, worse oral care).⁴

Neuroinflammation refers to immune-like responses inside the CNS, dominated by glial cells — especially microglia and astrocytes — that change activation states, release cytokines/chemokines, generate reactive species, and remodel synapses and vascular signaling.⁵ Neuroinflammation is not automatically “bad”: early microglial responses can help clear amyloid-β; chronic dysregulated activation can amplify synaptic dysfunction, vascular injury and tau-related neurodegeneration.⁶ Glial fibrillary acidic protein (GFAP) is a structural astrocyte protein that rises with reactive astrogliosis; blood GFAP has emerged as a practical biomarker associated with Alzheimer’s continuum biology and progression risk (while still not being perfectly specific).

Blood GFAP is a simple blood test that detects when astrocytes — brain support cells — are stressed and inflamed, serving as a practical marker for Alzheimer’s progression.⁷ Recent research demonstrates that Porphyromonas gingivalis (Pg) infection triggers astrocyte activation and GFAP upregulation in the brain as part of the inflammatory cascade driving cognitive decline, establishing a direct link between periodontal disease and Alzheimer’s pathology.⁸ This is the conceptual bridge: chronic oral inflammation can raise systemic inflammatory tone and deliver microbial signals that prime or trigger neuroinflammatory programs, especially in vulnerable brains.⁹

PERIODONTAL DISEASE
A key modern idea is that oral pathogens can influence the brain without needing a classic CNS infection. The pertinent mechanisms are (1) systemic inflammatory signaling and (2) vascular/barrier effects allowing peripheral immune and microbial products to perturb CNS homeostasis.¹⁰ Periodontal pathogens in the “red complex” — Pg, Treponema denticola (Td), and Tannerella forsythia (Tf) — are strongly associated with severe periodontitis biofilms.¹¹ Reviews and clinical observations suggest these organisms (and host responses to them) correlate with cognitive impairment signals in some cohorts.¹² The most mechanistically developed line involves Pg virulence factors, especially gingipains (proteases), and Pg-derived outer membrane vesicles (OMVs)—small bacterial particles that package LPS and proteases and can traffic systemically.¹³ In mice, Pg OMVs have been shown to induce memory deficits, neuroinflammation and tau phosphorylation. NLRP3 inflammasome is a cellular alarm system that detects danger signals from pathogens or damaged cells and activates the innate immune response by releasing inflammatory cytokines. When activated, NLRP3 assembles into a multiprotein complex that triggers caspase-1 to process and release IL-1β and IL-18, powerful signaling molecules that coordinate immune defense and inflammation throughout the body.¹⁴ This activation proposed as a mechanism directly connecting a periodontal virulence “packet” to tau-relevant pathology.¹⁵ Additional animal work shows that gingival exposure to Pg or Pg extracellular vesicles (pEVs) can induce periodontitis and cognitive impairment-like behavior, increase inflammatory signals in blood and hippocampus, and reduce protective neuronal/vascular markers, including claudin-5.¹⁶ This matters because the blood–brain barrier (BBB) is not just a wall; it’s an active neurovascular unit. Tight junction proteins, especially claudin-5, are core to BBB paracellular integrity.¹⁷ Periodontitis models have reported BBB disruption accompanied by changes in tight junction proteins and increased permeability, with systemic cytokines like IL-6 functioning as mediators.¹⁸ Pg OMVs can also directly injure endothelial barrier properties in vitro and in vivo, supporting vascular interface plausibility—again, not proof of causation in humans, but a coherent mechanism.¹⁹

VASCULAR AND METABOLIC PATHWAYS
The Lancet 2024 Commission highlights classic vascular and metabolic risks — especially hypertension and diabetes — as major contributors to dementia burden.¹ Periodontitis is associated with higher blood pressure and hypertension prevalence, and treatment can lower systemic inflammatory burden that plausibly contributes to vascular dysfunction.^20-22 Two specific vascular “operator-level” measures matter in dental settings: blood pressure
(BP) itself, and pulse pressure (PP = SBP-DBP). Elevated PP reflects arterial stiffness and is associated with BBB dysfunction and brain white matter injury mechanisms in vascular cognitive aging models; observational data link higher PP to increased dementia risk in some populations and to structural
brain changes and processing-speed effects.²³ Dental practices already measure blood pressure at every appointment as standard of care, making routine dental visits an untapped screening opportunity to detect undiagnosed hypertension in approximately 29 million Americans who see a dentist annually but no other medical professional.²⁴ The dental setting enables early identification of cardiovascular disease risk, often before symptoms appear, with over 80% of patients willing to have their pressure checked during dental appointments as part of integrated oral-systemic health care.²⁵

Panoramic radiographs can incidentally show carotid artery calcifications. Reviews emphasize that panoramic radiography is common in dentistry, carotid calcifications can be visible, and detection can support referral for confirmatory vascular evaluation — an opportunistic screening role rather than a definitive diagnosis.²⁶ Because carotid atherosclerosis is a stroke risk and vascular injury interacts with dementia pathways, this is one practical route where oral imaging intersects brain risk profiling.

Atrial fibrillation (AF) is a recognized vascular risk state for cognitive decline via embolic stroke, microinfarcts and hypoperfusion mechanisms. While historically viewed as an observational association, recent evidence confirms that periodontal disease directly contributes to an arrhythmogenic inflammatory substrate through both systemic signaling and direct bacterial translocation.²⁷ A Circulation paper provided direct mechanistic evidence linking oral pathogens to cardiac remodeling. Pg was shown to translocate into the bloodstream and infiltrate left atrial tissue, where it induces localized inflammatory signaling and promotes atrial fibrosis — creating the structural substrate for sustained arrhythmia.²⁸ Noteworthy, aggressive periodontal treatment during the three-month “blanking period” following atrial fibrillation ablation has been shown to improve rhythm stability. Reduction in periodontal inflamed surface area (PISA) was associated with a 61% lower risk of AF recurrence, identifying oral inflammation as a modifiable factor in post-ablation outcomes.²⁹

On the metabolic side, diabetes is both a dementia risk factor and tightly connected to periodontal inflammation in a bidirectional relationship.^30,31 Homocysteine is widely regarded as a modifiable vascular and metabolic stressor with strong evidence linking elevated levels to increased risk of Alzheimer’s disease and cognitive decline. It contributes to endothelial dysfunction, oxidative stress, and neuroinflammation – key pathways to Alzheimer’s pathogenesis.³² Periodontal inflammation has been associated with higher homocysteine levels, and emerging evidence suggests that periodontal therapy may help reduce these levels, highlighting a potential oral-systemic pathway influencing neurodegenerative risk.³³ Anemia contributes through impaired oxygen delivery and systemic inflammation. Observational studies link anemia to increased risk of cognitive decline and dementia, particularly when inflammatory markers (e.g., CRP) are elevated; this is applicable in multimorbidity, where chronic oral inflammation may contribute to systemic inflammatory load.³⁴

SLEEP – AIRWAY – OXYGENATION
Sleep and airway factors are increasingly implicated in dementia risk. Meta-analyses show obstructive sleep apnea (OSA) is associated with a higher risk
of cognitive impairment/all-cause dementia.³⁵ OSA also has a documented association with periodontitis in meta-analyses, consistent with shared inflammation/hypoxia pathways.³⁶ Mouth breathing associated with sleep-disordered breathing drives xerostomia, impairs salivary buffering and host defense, and increases the risk for caries, dysbiosis, and opportunistic infections, including candidiasis. Nasal breathing supports more efficient oxygen delivery by promoting nitric oxide–mediated vasodilation and better airflow through the lungs. This helps optimize oxygen exchange and blood flow, while also influencing brain activity through breathing patterns. Together, these effects link airway function to cerebral oxygenation and vascular regulation, which are important for brain health.^37-39

NOTED ORAL DISEASES
Meta-analyses report an association between HSV infection — particularly HSV 1 — and increased Alzheimer’s risk, though causality remains debated; some systematic reviews also examine whether antiviral treatment is associated with altered dementia risk signals.⁴⁰ Dental professionals can help manage recurrent lesions by using antiviral agents (e.g., acyclovir, valacyclovir) that inhibit viral DNA replication, while adjunctive low-level laser therapy (photobiomodulation) has been shown in clinical studies to reduce lesion duration, pain and may limit viral activity during outbreaks.⁴¹

Oral care is not “the cure” for Alzheimer’s disease. But dentistry is positioned to influence several modifiable upstream pathways:

Treat chronic oral inflammation (periodontitis, peri-implantitis). Periodontitis is associated with cognitive impairment and dementia risk in observational syntheses, and periodontal therapy reduces systemic inflammatory markers such as CRP in randomized meta-analyses. Periimplantitis is also associated with elevated systemic inflammation (CRP, IL-6), making chronic implant inflammation clinically significant beyond the oral cavity.

Measure blood pressure at every visit and recognize vascular patterns. Dental-office blood pressure screening can identify undiagnosed hypertension, and current professional guidance supports integrating screening and referral workflows into dental practice. Attention to pulse pressure and trends over time adds additional insight into vascular aging.

Read medical histories for vascular and metabolic red flags. Updated health histories can reveal patterns associated with elevated vascular risk, including hypertension, atrial fibrillation, stroke/TIA history, hyperlipidemia and sleep-disordered breathing. Recognizing these patterns allows for timely referral and coordination with medical care, aligning dental visits with broader prevention strategies.

Incorporate diabetes awareness and coordination of care. Type 2 diabetes is both a risk factor for cognitive decline and bidirectionally linked with periodontal inflammation. Poor glycemic control worsens periodontal disease, while periodontal therapy can improve glycemic measures in many studies. Identifying signs of dysglycemia and coordinating care supports both oral and systemic health.

Interpret panoramic radiographs with vascular awareness. Carotid artery calcifications are not uncommon on panoramic imaging; when identified, appropriate referrals can connect patients to vascular evaluation applicable to stroke and dementia prevention frameworks.

Treat caries and prevent tooth loss as cognitive-health–adjacent care. Tooth loss shows dose – response associations with cognitive impairment and dementia risk in meta-analyses, and longitudinal dental status correlates with cognitive performance in aging populations.

Address xerostomia, candidiasis risk and airway factors. Reduced salivary flow increases risk for caries and oral infections, including candidiasis. Sleep-disordered breathing, including obstructive sleep apnea, is associated with both periodontal disease and dementia risk, supporting screening and interdisciplinary care.

REFERENCES

1. Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572-628. doi:10.1016/S0140-6736(24)01296-0
2. Salminen A, Määttä AM, Mäntylä P, et al. Systemic Metabolic Signatures of Oral Diseases. J Dent Res. 2024;103(1):13-21. doi:10.1177/00220345231203562
3. Dibello V, Custodero C, Cavalcanti R, et al. Impact of periodontal disease on cognitive disorders, dementia, and depression: a systematic review and meta-analysis. Geroscience. 2024;46(5):5133-5169. doi:10.1007/s11357-024-01243-8
4. Demmer RT, Norby FL, Lakshminarayan K, et al. Periodontal disease and incident dementia: The Atherosclerosis Risk in Communities Study (ARIC). Neurology. 2020;95(12):e1660-e1671. doi:10.1212/WNL.0000000000010312
5. Adamu A, Li S, Gao F, Xue G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci. 2024;16:1347987. Published 2024 Apr 12. doi:10.3389/fnagi.2024.1347987
6. Valiukas Z, Tangalakis K, Apostolopoulos V, Feehan J. Microglial activation states and their implications for Alzheimer’s Disease. J Prev Alzheimers Dis. 2025;12(1):100013. doi:10.1016/j.tjpad.2024.100013
7. Kim KY, Shin KY, Chang KA. GFAP as a Potential Biomarker for Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Cells. 2023;12(9):1309. Published 2023 May 4. doi:10.3390/cells12091309
8. Kong L, Li J, Gao L, et al. Periodontitis-induced neuroinflammation triggers IFITM3-Aβ axis to cause alzheimer’s disease-like pathology and cognitive decline. Alzheimers Res Ther. 2025;17(1):166. Published 2025 Jul 19. doi:10.1186/s13195-025-01818-3
9. Bayraktaroglu I, Ortí-Casañ N, Van Dam D, De Deyn PP, Eisel ULM. Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease. Immun Ageing. 2025;22(1):33. Published 2025 Aug 21. doi:10.1186/s12979-025-00529-5 1
10. Beltran-Velasco AI, Clemente-Suárez VJ. Impact of Peripheral Inflammation on Blood-Brain Barrier Dysfunction and Its Role in Neurodegenerative Diseases. Int J Mol Sci. 2025;26(6):2440. Published 2025 Mar 9. doi:10.3390/ijms26062440
11. Cichońska D, Mazuś M, Kusiak A. Recent Aspects of Periodontitis and Alzheimer’s Disease-A Narrative Review. Int J Mol Sci. 2024;25(5):2612. Published 2024 Feb 23. doi:10.3390/ijms25052612
12. Zhang X, Huang X, Chang M. Association between periodontal disease and Alzheimer’s disease: a scoping review. Front Aging Neurosci. 2025;17:1588008. Published 2025 Oct 15. doi:10.3389/fnagi.2025.1588008
13. Butler CA, Ciccotosto GD, Rygh N, Bijlsma E, Dashper SG, Brown AC. Bacterial Membrane Vesicles: The Missing Link Between Bacterial Infection and Alzheimer Disease. J Infect Dis. 2024;230(Supplement_2):S87-S94. doi:10.1093/infdis/jiae228
14. Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int J Mol Sci. 2019;20(13):3328. Published 2019 Jul 6. doi:10.3390/ijms20133328
15. Gong T, Chen Q, Mao H, et al. Outer membrane vesicles of Porphyromonas gingivalis trigger NLRP3 inflammasome and induce neuroinflammation, tau phosphorylation, and memory dysfunction in mice. Front Cell Infect Microbiol. 2022;12:925435. Published 2022 Aug 9. doi:10.3389/fcimb.2022.925435
16. Ma X, Shin YJ, Yoo JW, Park HS, Kim DH. Extracellular vesicles derived from Porphyromonas gingivalis induce trigeminal nerve-mediated cognitive impairment. J Adv Res. 2023;54:293-303. doi:10.1016/j.jare.2023.02.006
17. Dithmer S, Blasig IE, Fraser PA, Qin Z, Haseloff RF. The Basic Requirement of Tight Junction Proteins in Blood-Brain Barrier Function and Their Role in Pathologies. Int J Mol Sci. 2024;25(11):5601. Published 2024 May 21. doi:10.3390/ijms25115601
18. Furutama D, Matsuda S, Yamawaki Y, et al. IL-6 Induced by Periodontal Inflammation Causes Neuroinflammation and Disrupts the Blood-Brain Barrier. Brain Sci. 2020;10(10):679. Published 2020 Sep 27. doi:10.3390/brainsci10100679
19. Mekata M, Yoshida K, Takai A, et al. Porphyromonas gingivalis outer membrane vesicles increase vascular permeability by inducing stress fiber formation and degrading vascular endothelial-cadherin in endothelial cells. FEBS J. 025;292(7):1696-1709. doi:10.1111/febs.17349
20. Yang H, Qin Y, Geng J, et al. Effect of age and systemic inflammation on the association between severity of periodontitis and blood pressure in periodontitis patients. BMC Oral Health. 2025;25(1):273. Published 2025 Feb 21. doi:10.1186/s12903-025-05665-4
21. Luo Y, Ye H, Liu W, et al. Effect of periodontal treatments on blood pressure. Cochrane Database Syst Rev. 2021;12(12):CD009409. Published 2021 Dec 12. doi:10.1002/14651858.CD009409.pub2
22. Czesnikiewicz-Guzik M, Osmenda G, Siedlinski M, et al. Causal association between periodontitis and hypertension: evidence from Mendelian randomization and a randomized controlled trial of non-surgical periodontal therapy. Eur Heart J. 2019;40(42):3459-3470. doi:10.1093/ eurheartj/ehz646
23. Levin RA, Carnegie MH, Celermajer DS. Pulse Pressure: An Emerging Therapeutic Target for Dementia. Front Neurosci. 2020;14:669. Published 2020 Jun 24. doi:10.3389/fnins.2020.00669
24. Manski R, Rohde F, Ricks T, et al. Trends in the Number and Percentage of the Population with Any Dental or Medical Visits, 2019. 2022 Oct. In: Statistical Brief (Medical Expenditure Panel Survey (US)) [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2001-. STATISTICAL BRIEF #544
25. American Heart Association. New resources help dentists identify patients at risk for cardiovascular disease. Published November 18, 2025. Updated January 26, 2026. Accessed April 13, 2026. https://newsroom.heart.org/news/new-resources-help-dentists-identify-patients-at-risk-forcardiovascular-disease
26. Brar A, DeColibus K, Rasner DS, et al. Carotid Artery Calcification Detected on Panoramic Radiography Is Significantly Related to Cerebrovascular Accident, Coronary Artery Disease, and Poor Oral Health: A Retrospective Cross-Sectional Study. Dent J (Basel). 2024;12(4):99. Published 2024 Apr 10. doi:10.3390/dj12040099
27. Leelaviwat N, Kewcharoen J, Poomprakobsri K, et al. Periodontal disease and risk of atrial fibrillation or atrial flutter: A systematic review and meta-analysis. J Arrhythm. 2023;39(6):992-996. Published 2023 Sep 14. doi:10.1002/joa3.12921
28. Miyauchi S, Nishi H, Ouhara K, et al. Atrial translocation of Porphyromonas gingivalis exacerbates atrial fibrosis and atrial fibrillation. Circulation. 2025;151(21):1527-1540. doi:10.1161/CIRCULATIONAHA.124.071310
29. Miyauchi S, Nishi H, Ouhara K, et al. Periodontal treatment during the blanking period after atrial fibrillation ablation and risk of recurrence. J Am Heart Assoc. 2024;13(6):e032682. doi:10.1161/JAHA.123.032682
30. International Diabetes Federation Diabetes Atlas Committee. Diabetes and oral health: summary of current evidence and clinical recommendations. Diabetes Res Clin Pract. 2020;161:108084. doi:10.1016/j.diabres.2020.108084
31. Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591-604. doi:10.1038/s41574-018-0048-7
32. Zuin M, Cervellati C, Brombo G, Trentini A, Roncon L, Zuliani G. Elevated Blood Homocysteine and Risk of Alzheimer’s Dementia: An Updated Systematic Review and Meta-Analysis Based on Prospective Studies. J Prev Alzheimers Dis. 2021;8(3):329-334. doi:10.14283/ jpad.2021.7
33. Penmetsa GS, Bhaskar RU, Mopidevi A. Analysis of Plasma Homocysteine Levels in Patients with Chronic Periodontitis Before and After Nonsurgical Periodontal Therapy Using High-Performance Liquid Chromatography. Contemp Clin Dent. 2020;11(3):266-273. doi:10.4103/ccd. ccd_650_18
34. Jeong SM, Shin DW, Lee JE, et al. Anemia is associated with incidence of dementia: a national health screening study in Korea involving 37,900 persons. Alzheimers Res Ther. 2017;9(1):94. doi:10.1186/s13195-017-0322-2
35. Tian Q, Sun J, Li X, et al. Association between sleep apnea and risk of cognitive impairment and Alzheimer’s disease: a meta-analysis of cohortbased studies. Sleep Breath. 2024;28(2):585-595. doi:10.1007/s11325-023-02934-w
36. Liu X, Zhu Z, Zhang P. Association between sleep-disordered breathing and periodontitis: a meta-analysis. Med Oral Patol Oral Cir Bucal. 2023;28(2):e156-e166. Published 2023 Mar 1. doi:10.4317/medoral.25627
37. Watso JC, et al. Acute nasal breathing lowers diastolic blood pressure and modulates autonomic function via nitric oxide–mediated pathways. Am J Physiol Regul Integr Comp Physiol. 2023;325(1):Rxx–Rxx. doi:10.1152/ajpregu.00148.2023
38. Eser P, et al. Improved exercise ventilatory efficiency with nasal breathing: implications for oxygen utilization and pulmonary vascular resistance. Front Physiol. 2024;15:1380562. doi:10.3389/fphys.2024.1380562
39. Chen K, et al. Dynamic brain network modulation by nasal breathing and oxygen-related mechanisms. Front Physiol. 2025;16:1722715
40. Ji Q, Lian W, Liu W, et al. Herpes Simplex Virus Infection and Risk of Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Neuroepidemiology. Published online September 11, 2025. doi:10.1159/000548365
41. Lasers in Medical Science Muñoz Sanchez PJ, Capote Femenías JL, Díaz Tejeda A, et al. The effect of low-level laser therapy on herpes labialis: a systematic review. Lasers Med Sci. 2012;27(5):—. doi:10.1007/s10103-011-0952-5

Anne O. Rice, BS, RDH, has been a dental hygienist for 35 years. She created Oral Systemic Seminars in 2017 and now devotes much of her time, focus and study to dementia prevention. She is a preceptor for the Bale/Doneen method, a Certified Dementia Practitioner and a Longevity Specialist with the Alzheimer’s Research and Prevention Foundation, where she has also developed curriculum. Anne is a Fellow with The American Academy for Oral Systemic Health and serves on their advisory board. She was included in an International Consortium of a diverse network of brain researchers, clinicians and institutions who support Alzheimer’s prevention. Her consulting has brought her to Weill Cornell Medical Center’s Alzheimer’s Prevention Clinic, Florida Atlantic College Center for Brain Health, the Atria Health and Research Institute and Florida Institute Neurodegenerative Diseases.